Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

CME Group (CME) Poised For Earnings Growth: Time To Buy?

Published 08/09/2016, 09:58 PM
Updated 07/09/2023, 06:31 AM

On Aug 9, 2016, Zacks Investment Research upgraded CME Group Inc. (NASDAQ:CME) to Zacks Rank #2 (Buy).

Why the Upgrade?

CME Group has been witnessing a rise in earnings estimates on the back of strong second-quarter 2016 results. This securities exchange reported earnings of $1.14 that surpassed the Zacks Consensus Estimate by 2.7%. Earnings improved 15.2% year over year on record average daily volumes.

In the second quarter, the company witnessed a rise in contract volumes across geographies. In Europe, volumes in five of the company’s product areas surged more than 20%, with the strongest growth in energy and equities. In Asia, energy and metal volumes soared more than 140% and 80%, respectively. Latin America also demonstrated growth on the back of higher energy volumes.

CME Group witnessed solid revenue growth as well as cost-control induced margin expansion and earnings improvement in the second quarter. Four out of the company’s six product lines registered more than 20% year-over-year increase in volume and transaction fee revenues. CME Group reported revenue growth of 11% in the second quarter.

Additionally, its open interest reached an all-time high of more than 116 million contracts. This reflects an increased reliance of market participants on CME Group.

During the second quarter, CME Group became the first exchange to offer swaptions clearing that will enable clients to obtain the greater operational and capital efficiencies from clearing. This is expected to help the company develop more specialized products going forward. Recently, the company also progressed with its initiatives to enhance Live Cattle futures markets with feedback from the cattle industry.

The Zacks Consensus Estimate for 2016 moved up 2.8% to $4.47 per share as 88% of the estimates were revised higher over the last 30 days. For 2017, 88% estimates were revised higher over the same time frame, which raised the Zacks Consensus Estimate by 2.8% to $4.82 per share.

CME Group is well positioned for growth supported by its diverse derivative product lines. Also, the launch of products and effective capital deployment strengthen the company. In addition, its increasing global presence and meaningful acquisitions raise optimism. The long-term earnings growth is pegged at 9.7%.

CME GROUP INC Price and Consensus

CME GROUP INC Price and Consensus | CME GROUP INC Quote

Stocks to Consider

Investors interested in the finance sector can look for MarketAxess Holdings Inc. (NASDAQ:MKTX) , Allied World Assurance Company Holdings, AG (NYSE:AWH) and Argo Group International Holdings, Ltd. (NASDAQ:AGII) . All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7Best Stocks for the Next 30 Days. Click to get this free report >>



ARGO GROUP INTL (AGII): Free Stock Analysis Report

ALLIED WORLD AS (AWH): Free Stock Analysis Report

CME GROUP INC (CME): Free Stock Analysis Report

MARKETAXESS HLD (MKTX): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.